Xeljanz 11 mg, tablet met verlengde afgifte

{
  "form": "Tablet met verlengde afgifte",
  "route": "Oraal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/xeljanz-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Tofacitinib",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp122930",
  "excipients": [
    "AMMONIA (E 527)",
    "CELLULOSEACETAAT",
    "COPOVIDON (E 1208)",
    "GLYCEROLTRIACETAAT (E 1518)",
    "HYDROXYETHYLCELLULOSE",
    "HYPROLOSE (E 463)",
    "HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
    "IJZEROXIDE ROOD  (E 172)",
    "IJZEROXIDE ZWART (E 172)",
    "MAGNESIUMSTEARAAT (E 470b)",
    "PROPYLEENGLYCOL (E 1520)",
    "SCHELLAK GLAZE, GEDEELTELIJK VERESTERD",
    "SORBITOL (E 420)",
    "TITAANDIOXIDE (E 171)",
    "ZWARTE INKT"
  ],
  "substances": [
    "TOFACITINIBCITRAAT"
  ],
  "leaflet_url": null,
  "authorised_at": "2019/12/16",
  "procedure_number": "EMEA/H/C/004214",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/17/1178",
  "additional_monitoring": "N"
}